Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,treasuryStock,cash,totalCurrentLiabilities,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,longTermInvestments,longTermDebt,accountsPayable,intangibleAssets,otherAssets,netReceivables,changeToLiabilities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,effectOfExchangeRate,totalCashFromOperatingActivities,changeToAccountReceivables,changeToNetincome,investments,totalCashflowsFromInvestingActivities,depreciation,WC,language,region,quoteType,triggerable,quoteSourceName,currency,priceHint,exchange,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,exchangeDataDelayedBy,shortName,marketState,market,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,epsTrailingTwelveMonths,bookValue,fiftyDayAverage,fiftyDayAverageChange,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,esgPopulated,tradeable,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,country,website,maxAge,address1,fax,industry
t0,NMI.DE,-2237257.0,11458200,53000,,-421188,,-421072,130500,0,-402015,-402015,218515,-19173,,,,-116,0,402015,0,-19173,,-421072,-421072,2436971.0,-2237257.0,405093.0,199714.0,11458238.0,1664.0,-10245105.0,-1.0,-3450390.0,80340.0,2236972.0,-3450390.0,4121.0,82004.0,113589.0,200000.0,229879.0,,,,-25041.0,100000.0,104119.0,3166.0,4119.0,39793.0,-15.0,-64311.0,177228.0,201408.0,,,,-2154968.0,en-US,US,EQUITY,False,Delayed Quote,EUR,4,GER,0.239,1630510575,0.0,0.1905,0.239,0.1905,4400,0,ALADDIN HLTHC.TECH. O.N.,REGULAR,de_market,0.0,0.1905 - 0.239,0.239,0.1915,0.257,finmb_276571517,XETRA,Aladdin Healthcare Technologies SE,EUR,12746,12005,0.048499987,0.2545931,0.1905 - 1.62,-1.381,-0.85246915,0.1905,1.62,-0.11142986,0.40059155,-0.16159156,-0.40338233,-0.251,-0.195,0.26897144,-0.02997145,2738509,-1.225641,15,Europe/Berlin,CEST,7200000,False,False,-0.09,,,1.62,0.1905,0.269,0.4006,12.75k,12.01k,11.46M,,11.12M,,,,,,,,,,,,,0.00%,,,,,"Dec 31, 2019","Jun 30, 2020",0.00%,0.00%,-44.69%,-781.40%,,,,,-1.8M,-2.87M,-0.2510,,80.34k,0.01,1.8M,,0.04,-0.19,-902.5k,-470.57k,Value,10117,Healthcare,3,"Aladdin Healthcare Technologies SE, through its subsidiary, Aladdin Healthcare Technologies Ltd, develops software solutions for the storage and management of health information using blockchain technology. It specializes in technologies, such as blockchain, machine learning, and artificial intelligence. The company engages in the research and development of Artificial Intelligence Early Diagnosis, an artificial intelligence powered data analysis platform for brain imaging; Health Risk Assessment Platform that assesses the risk of cardiovascular, as well as diabetes and kidney related diseases in patients; and Artificial Intelligence assisted Drug Discovery Platform to identify various small molecule drug compounds with multiple age-related diseases, including Alzheimer's, Parkinson's, and SARS-CoV-2. It uses blockchain, machine learning, artificial intelligence, and advanced predictive data analytics for the early diagnosis of chronic diseases. The company was founded in 2014 and is based in Berlin, Germany.",Berlin,49 30 700 140 449,Germany,http://www.aladdinid.com,86400,Unter den Linden 10,49 30 700 140 150,Health Information Services
t-1,NMI.DE,-2237257.0,11458200,53000,,-421188,,-421072,130500,0,-402015,-402015,218515,-19173,,,,-116,0,402015,0,-19173,,-421072,-421072,2436971.0,-2237257.0,405093.0,199714.0,11458238.0,1664.0,-10245105.0,-1.0,-3450390.0,80340.0,2236972.0,-3450390.0,4121.0,82004.0,113589.0,200000.0,229879.0,,,,-25041.0,100000.0,104119.0,3166.0,4119.0,39793.0,-15.0,-64311.0,177228.0,201408.0,,,,-2154968.0,en-US,US,EQUITY,False,Delayed Quote,EUR,4,GER,0.239,1630510575,0.0,0.1905,0.239,0.1905,4400,0,ALADDIN HLTHC.TECH. O.N.,REGULAR,de_market,0.0,0.1905 - 0.239,0.239,0.1915,0.257,finmb_276571517,XETRA,Aladdin Healthcare Technologies SE,EUR,12746,12005,0.048499987,0.2545931,0.1905 - 1.62,-1.381,-0.85246915,0.1905,1.62,-0.11142986,0.40059155,-0.16159156,-0.40338233,-0.251,-0.195,0.26897144,-0.02997145,2738509,-1.225641,15,Europe/Berlin,CEST,7200000,False,False,-0.09,,,1.62,0.1905,0.269,0.4006,12.75k,12.01k,11.46M,,11.12M,,,,,,,,,,,,,0.00%,,,,,"Dec 31, 2019","Jun 30, 2020",0.00%,0.00%,-44.69%,-781.40%,,,,,-1.8M,-2.87M,-0.2510,,80.34k,0.01,1.8M,,0.04,-0.19,-902.5k,-470.57k,Value,10117,Healthcare,3,"Aladdin Healthcare Technologies SE, through its subsidiary, Aladdin Healthcare Technologies Ltd, develops software solutions for the storage and management of health information using blockchain technology. It specializes in technologies, such as blockchain, machine learning, and artificial intelligence. The company engages in the research and development of Artificial Intelligence Early Diagnosis, an artificial intelligence powered data analysis platform for brain imaging; Health Risk Assessment Platform that assesses the risk of cardiovascular, as well as diabetes and kidney related diseases in patients; and Artificial Intelligence assisted Drug Discovery Platform to identify various small molecule drug compounds with multiple age-related diseases, including Alzheimer's, Parkinson's, and SARS-CoV-2. It uses blockchain, machine learning, artificial intelligence, and advanced predictive data analytics for the early diagnosis of chronic diseases. The company was founded in 2014 and is based in Berlin, Germany.",Berlin,49 30 700 140 449,Germany,http://www.aladdinid.com,86400,Unter den Linden 10,49 30 700 140 150,Health Information Services
t-2,NMI.DE,251138.0,11458200,53000,,-481327,,-481327,246639,0,-464979,-464979,464979,-19744,,,,0,0,464979,0,-16349,,-481327,-481327,1869894.0,2971672.0,408403.0,4841566.0,11450000.0,,-4883036.0,1.0,-3595292.0,17991.0,1869893.0,-3595292.0,4990.0,341175.0,111660.0,,199619.0,2720534.0,1663207.0,323184.0,64533.0,623313.0,623313.0,3166.0,4119.0,-45680.0,-15.0,-492715.0,-103933.0,27611.0,-175.0,-176278.0,403.0,-1528718.0,en-US,US,EQUITY,False,Delayed Quote,EUR,4,GER,0.239,1630510575,0.0,0.1905,0.239,0.1905,4400,0,ALADDIN HLTHC.TECH. O.N.,REGULAR,de_market,0.0,0.1905 - 0.239,0.239,0.1915,0.257,finmb_276571517,XETRA,Aladdin Healthcare Technologies SE,EUR,12746,12005,0.048499987,0.2545931,0.1905 - 1.62,-1.381,-0.85246915,0.1905,1.62,-0.11142986,0.40059155,-0.16159156,-0.40338233,-0.251,-0.195,0.26897144,-0.02997145,2738509,-1.225641,15,Europe/Berlin,CEST,7200000,False,False,-0.09,,,1.62,0.1905,0.269,0.4006,12.75k,12.01k,11.46M,,11.12M,,,,,,,,,,,,,0.00%,,,,,"Dec 31, 2019","Jun 30, 2020",0.00%,0.00%,-44.69%,-781.40%,,,,,-1.8M,-2.87M,-0.2510,,80.34k,0.01,1.8M,,0.04,-0.19,-902.5k,-470.57k,Value,10117,Healthcare,3,"Aladdin Healthcare Technologies SE, through its subsidiary, Aladdin Healthcare Technologies Ltd, develops software solutions for the storage and management of health information using blockchain technology. It specializes in technologies, such as blockchain, machine learning, and artificial intelligence. The company engages in the research and development of Artificial Intelligence Early Diagnosis, an artificial intelligence powered data analysis platform for brain imaging; Health Risk Assessment Platform that assesses the risk of cardiovascular, as well as diabetes and kidney related diseases in patients; and Artificial Intelligence assisted Drug Discovery Platform to identify various small molecule drug compounds with multiple age-related diseases, including Alzheimer's, Parkinson's, and SARS-CoV-2. It uses blockchain, machine learning, artificial intelligence, and advanced predictive data analytics for the early diagnosis of chronic diseases. The company was founded in 2014 and is based in Berlin, Germany.",Berlin,49 30 700 140 449,Germany,http://www.aladdinid.com,86400,Unter den Linden 10,49 30 700 140 150,Health Information Services
t-3,NMI.DE,251138.0,11458200,53000,,-481327,,-481327,246639,0,-464979,-464979,464979,-19744,,,,0,0,464979,0,-16349,,-481327,-481327,1869894.0,2971672.0,408403.0,4841566.0,11450000.0,,-4883036.0,1.0,-3595292.0,17991.0,1869893.0,-3595292.0,4990.0,341175.0,111660.0,,199619.0,2720534.0,1663207.0,323184.0,64533.0,623313.0,623313.0,3166.0,4119.0,-45680.0,-15.0,-492715.0,-103933.0,27611.0,-175.0,-176278.0,403.0,-1528718.0,en-US,US,EQUITY,False,Delayed Quote,EUR,4,GER,0.239,1630510575,0.0,0.1905,0.239,0.1905,4400,0,ALADDIN HLTHC.TECH. O.N.,REGULAR,de_market,0.0,0.1905 - 0.239,0.239,0.1915,0.257,finmb_276571517,XETRA,Aladdin Healthcare Technologies SE,EUR,12746,12005,0.048499987,0.2545931,0.1905 - 1.62,-1.381,-0.85246915,0.1905,1.62,-0.11142986,0.40059155,-0.16159156,-0.40338233,-0.251,-0.195,0.26897144,-0.02997145,2738509,-1.225641,15,Europe/Berlin,CEST,7200000,False,False,-0.09,,,1.62,0.1905,0.269,0.4006,12.75k,12.01k,11.46M,,11.12M,,,,,,,,,,,,,0.00%,,,,,"Dec 31, 2019","Jun 30, 2020",0.00%,0.00%,-44.69%,-781.40%,,,,,-1.8M,-2.87M,-0.2510,,80.34k,0.01,1.8M,,0.04,-0.19,-902.5k,-470.57k,Value,10117,Healthcare,3,"Aladdin Healthcare Technologies SE, through its subsidiary, Aladdin Healthcare Technologies Ltd, develops software solutions for the storage and management of health information using blockchain technology. It specializes in technologies, such as blockchain, machine learning, and artificial intelligence. The company engages in the research and development of Artificial Intelligence Early Diagnosis, an artificial intelligence powered data analysis platform for brain imaging; Health Risk Assessment Platform that assesses the risk of cardiovascular, as well as diabetes and kidney related diseases in patients; and Artificial Intelligence assisted Drug Discovery Platform to identify various small molecule drug compounds with multiple age-related diseases, including Alzheimer's, Parkinson's, and SARS-CoV-2. It uses blockchain, machine learning, artificial intelligence, and advanced predictive data analytics for the early diagnosis of chronic diseases. The company was founded in 2014 and is based in Berlin, Germany.",Berlin,49 30 700 140 449,Germany,http://www.aladdinid.com,86400,Unter den Linden 10,49 30 700 140 150,Health Information Services
